[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.83.210. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 146
Citations 0
Comment & Response
April 2015

Apolipoprotein E and Neurocognitive Function—Reply

Author Affiliations
  • 1Cardiovascular Research Institute, University of California, San Francisco
  • 2Neurology/Memory and Aging Center, University of California, San Francisco
JAMA Neurol. 2015;72(4):479. doi:10.1001/jamaneurol.2014.4699

In Reply We appreciate the astute comments from Cullum and Weiner. The neuropsychological evaluation of our patient included the standard tests performed on patients coming to the University of California, San Francisco, Memory and Aging Center.1 His performance on some items was indeed below average. It is important to note that the patient came from a socially deprived environment and had profound disadvantages during childhood. Additionally, dyslexia was suspected from our clinical history. He had no history of progressive cognitive or functional deterioration, and we did not consider it correct to label him as cognitively impaired. Of seminal importance in this case is the observation that the total absence of apolipoprotein E, normally present in brain and with demonstrated roles in the transport of myelin lipids, can be associated with relatively normal development and adulthood without critically impairing neurological functions. We will, of course, continue to monitor him for evidence of any changes in his neurological and psychological functioning.

First Page Preview View Large
First page PDF preview
First page PDF preview
×